HC Surgical Specialists Announces Interim Dividend and Record Date

Singapore – HC Surgical Specialists Limited has officially announced the details of its interim dividend for the financial year ending 31 May 2025. The announcement may influence shareholder sentiment and share price movements as it provides insights into the company’s financial health and shareholder return strategies.

Key Highlights

• The company will pay an ordinary tax-exempt (one-tier) interim dividend of 0.80 cents per ordinary share.
• Record Date: Shareholders must ensure their shares are duly registered by 5:00 PM on 3 March 2025 to qualify for the dividend.
• Payment Date: The interim dividend will be disbursed on 13 March 2025.

Important Information for Shareholders

Shareholders are advised to take note of the following critical details to secure their entitlement:

• Transfers of shares must be completed and received by the company’s Share Registrar, Tricor Barbinder Share Registration Services, located at 9 Raffles Place, #26-01 Republic Plaza, Singapore 048619, before the cut-off time of 5:00 PM on 3 March 2025.
• For depositors with securities accounts maintained at The Central Depository (Pte) Limited, shares must be credited to their accounts by the same 5:00 PM deadline on 3 March 2025 to qualify.

This dividend declaration reflects HC Surgical Specialists’ confidence in its financial performance and commitment to returning value to its shareholders.

About HC Surgical Specialists Limited

Established in 2015 and listed on the Catalist board of the Singapore Exchange in 2016, HC Surgical Specialists Limited operates as a medical services provider with a focus on endoscopic procedures and colorectal surgeries. The company has a network of 18 clinics across Singapore, providing essential healthcare services.

Market Implications

Dividend announcements often impact share prices, as they signal the company’s profitability and commitment to rewarding shareholders. The declared interim dividend and the consistent financial performance suggested by this announcement could positively influence HC Surgical Specialists’ stock price. Investors may view this as an opportunity to invest or hold shares in the company.

Shareholders are encouraged to act promptly to meet the record date requirements and maximize their benefits. Any delay in share transfers or account credits could result in missed entitlements.

Disclaimer

This article is for informational purposes only and does not constitute financial advice. Investors are advised to conduct their own research or consult with a professional financial advisor before making investment decisions. The writer and publisher of this article assume no responsibility for any financial outcomes resulting from the information provided.

View HC Surgical Historical chart here